Skip to main content
Fig. 3 | Journal for ImmunoTherapy of Cancer

Fig. 3

From: Radiation myelitis after pembrolizumab administration, with favorable clinical evolution and safe rechallenge: a case report and review of the literature

Fig. 3

Dosimetry study for the site of myelitis. a and b present an image fusion between the MRI showing the location of the myelitis (gadolinium-enhanced fat-saturated T1-weighted) and the treatment plan. The angle beams used: one anterior and two oblique posterior beams. The green isodose represents 98% of the prescribed dose (29.3 Gy) and the yellow isodose 103% of the prescribed dose (30.9 Gy). On both pictures, we can see that the dose received at the site of myelitis is 30 Gy

Back to article page